AD patients as well as MCI subjects, who cognitively declined and thus converted to AD within 3 years of follow-up (pMCI), exhibited significantly larger baseline BrainAGE scores compared to control subjects and those with MCI, who remained cognitively stable (sMCI), but did not differ between APOE ε4 carriers and non-carriers. Here, APOE is linked to Alzheimer disease.